PurpleAI Logo

Hyper Insight™ – ASPECTS

Hyper Insight™ Stroke AI

One platform across the stroke pathway — hemorrhage, infarction, aneurysm, perfusion and 3D vascular imaging, on CT and MR. One solution is FDA-cleared today; seven more are in the FDA process. Select any solution for its description, capabilities, and performance evidence.

Hyper Insight™ – ASPECTS

NCCTLaunched · KRMFDS ApprovedFDA in ProgressPre-FDA Access

Automated ASPECTS scoring on non-contrast brain CT.

Capabilities
  • Automated ASPECTS scoring
  • Colored mapping of brain regions
  • Intuitive reporting
NCCTASPECTS
ASPECTS 1Click to zoom
Performance & evidence

Shares the Infarct multi-center dataset (N=917, nine reviewers) and the four-institution external validation (N=1,400 — 700 acute ischemic stroke / 700 controls).